Status:
COMPLETED
Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' Gestation
Lead Sponsor:
Gynuity Health Projects
Conditions:
Pregnancy
Eligibility:
FEMALE
18-50 years
Phase:
PHASE2
Brief Summary
Study to determine if a user-friendly medical abortion regimen using letrozole and misoprostol is safe and acceptable.
Eligibility Criteria
Inclusion
- Pregnancy ≤ 63 days gestational age by ultrasound seeking termination of pregnancy
- Pregnancy visible on ultrasound
- Speaks English or Spanish
- Willing and able to return for follow-up appointment
Exclusion
- People with gestations \> 63 days gestational age
- Confirmed or suspected ectopic pregnancy or undiagnosed adnexal mass
- Pregnancy of unknown location
- IUD or contraceptive implant in place
- History of allergy to letrozole or misoprostol
- Unable to return for clinic-based follow-up
- Currently breastfeeding
- Twin or multiple pregnancy
- History of liver disease or abnormal liver function
Key Trial Info
Start Date :
December 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05207644
Start Date
December 9 2021
End Date
April 30 2022
Last Update
June 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Planned Parenthood Salt Lake Health Center
Salt Lake City, Utah, United States, 84102